Orchid Pharma Q4 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
948.00
-6.70 (-0.70%)
-6.70 (-0.70%)Volume532.00
Updated: Mon 7 Sep, 2026 | 15:27:02
NSE
946.45-8.20 (-0.86%)
-8.20 (-0.86%)Volume12.35 K
Updated: Mon 7 Sep, 2026 | 15:29:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Orchid Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 219.07 | 221.85 | -1.25% | 195.69 | 0.32% |
| Depreciation/ Amortization | 8.87 | 9.03 | -1.79% | 8.42 | -0.04% |
| Operating Income | 18.54 | -14.58 | 0.00% | 21.41 | -3.01% |
| Net Income | 23.78 | -12.61 | 0.00% | 33.53 | 6.66% |
| Other Operating Expenses Total | 38.51 | 38.43 | 0.20% | 42.43 | -21.79% |
| Net Income Before Taxes | 22.79 | -12.15 | 0.00% | 30.95 | 19.34% |
| Total Revenue | 237.61 | 207.27 | 14.64% | 217.10 | 0.05% |
| Selling/ General/ Admin Expenses Total | 20.88 | 24.13 | -13.47% | 16.72 | -6.13% |
| Diluted Normalized EPS | 4.52 | -1.09 | 0.00% | 6.62 | 2.85% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.